StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Celgene (CELG) Maintained Outperform at Oppenheimer, Defends Name
October 26, 2017 10:40 AM
Oppenheimer maintains Outperform on Celgene (NASDAQ: CELG) price target of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Celgene (CELG) Remains In The Good Graces of Oppenheimer
October 27, 2017 11:09 AM
Mizuho is Positive on Celgene (CELG)
October 27, 2017 10:31 AM
Celgene (CELG) PT Lowered to $125 at Jefferies; Reiterates Buy
October 27, 2017 8:40 AM
Cantor Fitzgerald Downgrades Celgene (CELG) to Neutral
October 27, 2017 7:36 AM
UPDATE: Morgan Stanley Upgrades Celgene (CELG) to Equalweight
October 27, 2017 5:57 AM
JMP Securities Downgrades Celgene (CELG) to Market Perform Citing Valuation
October 27, 2017 3:16 AM
Raymond James Double Downgrades Celgene (CELG) to Market Perform
October 26, 2017 3:57 PM
Wells Fargo Downgrades Celgene (CELG) to Market Perform, Cuts PT 'on Serial Disappointment'
October 26, 2017 10:52 AM
Celgene (CELG) Tops Q3 EPS by 4c, Sales Miss; Raises Low End of FY EPS Guidance, Offers 2020 Targets
October 26, 2017 7:34 AM
